Find all relevant presentations and publications for each of our programs. From review papers to preclinical posters and clinical data presentations at medical conferences.
… ProQR Announces R&D Day and Provides Update on Innovation Portfolio First Investor R&D Day on March 14, 2016 … amaurosis (LCA), today presents an update on the innovation pipeline and announces an R&D day for investors. …
… ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10 … only by market approval of QR-110. Innovation credit (“Innovatiekrediet”) The Innovation Credit is awarded by the …
… ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision … at the 7th Annual Retinal Cell and Gene Therapy Innovation Summit being held Friday, April 29, 2022 and the … U.S. Presentations at the Retinal Cell and Gene Therapy Innovation Summit Presentation title: AON treatment for …
ProQR invented an entirely new way to treat genetic diseases. Axiomer enables RNA base editing by recruiting ADAR so your own body can treat disease. Learn more here.
… the pipeline behind the CF program from ProQR's internal innovation (discovery) unit and the Company intends to start … of QR-010. Horizon 2020 is one of the largest research and innovation programs in the European Union with nearly €80 …
… oligonucleotides for severe genetic diseases through our innovation unit.” Financial Highlights At June 30, 2016, … preclinical development of QR-110 and progress of our innovation programs such as QR-313 for epidermolysis bullosa, …
